20Jan 2020

HYPOFRACTIONATED RADIOTHERAPY IN BREAST CANCER: CAN IT BECOME A STANDARD

  • Radiation-Oncology Department, Mohammed VI University Hospital, Marrakech
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Radiation therapy has long demonstrated its benefit of local control in breast cancer, but also of recurrence and overall survival. However, this treatment is not stripped of constraints, essentially socio-economic: Few centers for a large number of patients, long duration of treatment occupying the majority of the activity of a radiotherapy service, high cost for patients living in remote regions. Which made think of more practical schemes in hypofractionation for a shorter duration of treatment. Indeed, hypofractionated radiotherapy is currently said to be equivalent to conventional irradiation in breast cancer in terms of local control for patients regardless of age or stage after conservative surgery, but not yet validated in the event of invasion lymph node or after mastectomy. Our study gathered 60 patients with breast cancer, at different stages, of which 75% had lymph node invasion and 72% operated by patey, with or without the presence of factors of poor prognosis (vascular embolism, SBR III, negative RH, Her2 positive), noting that only one patient had not received chemotherapy. The results in terms of overall survival and recurrence at 5 years after hypofractionated protocols have been very encouraging, which may suggest the adoption of these regimens more commonly.


  1. Whelan TJ, Pignol J-P, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513?520.
  2. START Trialists? Group, Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.?Lancet Lond Engl. 29 mars 2008;371(9618):1098‑107.
  3. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK standardisation of breast radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331?41.
  4. Group FT, Agrawal RK, Alhasso A, Barrett-Lee PJ, Bliss JM, Bliss P, et al. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 2011;100:93?100.
  5. Yarnold J, Bentzen SM, Coles C, Haviland J. Hypofractionated Whole-Breast Radiotherapy for Women With Early Breast Cancer: Myths and Realities. Int J Radiat Oncol. janv 2011;79(1):1‑9.
  6. Trialists? Group TS. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9(4):331?341.
  7. START Trialists? Group, Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.?Lancet Lond Engl. 29 mars 2008;371(9618):1098‑107.
  8. Besnard S, Cutuli B, Fourquet A, Giard S, Hennequin C, Leblanc-Onfroy M, et al. [Radiotherapy of invasive breast cancer: French national guidelines]. Cancer Radioth?rapie J Soci?t? Fr Radioth?rapie Oncol. sept 2012;16(5‑6):503‑13.

[H. Sami, S. Barkiche, S. Elouarzazi, H. Eddaoualline, M. Darfaoui, I. Lalya, A. Elomrani and M. Khouchani (2020); HYPOFRACTIONATED RADIOTHERAPY IN BREAST CANCER: CAN IT BECOME A STANDARD Int. J. of Adv. Res. 8 (1). 203-208] (ISSN 2320-5407). www.journalijar.com


Hind SAMI
Radiotherapy-Oncology

DOI:


Article DOI: 10.21474/IJAR01/10284       DOI URL: http://dx.doi.org/10.21474/IJAR01/10284


Share this article